-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZPATH AND QUANTERIX EXPAND STRATEGIC LICENSING AGREEMENT TO ADVANCE NEXT GENERATION ALZHEIMER'S DISEASE BIOMARKER RESEARCH

Reuters·10/07/2026 12:32:27

Please log in to view news